Laboratorios Farmaceuticos Rovi S.A.
ISIN: ES0157261019 | Ticker: ROVI
ROVI is a fully integrated Spanish specialty pharmaceutical company engaged in the research, development, in-licensing, manufacturing and marketing of small molecule and specialty biologic drugs.
To date, thanks to our 22 alliances with international partners, our principal product, Bemiparin, is now present in more than 55 countries.
With our Enoxaparin Biosimilar, we hope to increase our presence in Europe, the United States and emerging countries.
1946
Served areaWorldwide
Headcount1,209
HeadquartersCl Julian Camarillo 35, 28037 Madrid – Spain
56,068,965
IPODec. 5, 2007
Stock exchange(s)Bolsa de Madrid